Feed THLEF
TH

Thales S.A.

THLEF · OTC

$270.75 +0.41% (+$1.11)
1M -12.51%
Market Cap 48.3B €
P/E Ratio 28.83x
Div. Yield 1.68%
ROE 21.87%

Bulios Fair Price

$337.66

24.7% upside

Current Price

$270.75

Undervalued Fair Value Overvalued

According to Bulios Fair Price, THLEF is currently undervalued relative to its market price. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Piotroski F-Score Strong
8/9
Valuation
52 /100
Fair
P/E 28.83x
PEG 1.61x
EV/EBITDA 15.11x
Growth
57 /100
Stable
EPS growth 15.84%
Book val. growth 3.55%
Rev. growth 7.99%
Profitability
55 /100
Moderate
Gross margin 26.44%
FCF margin 11.90%
Net margin 7.56%
Quality
68 /100
Excellent
ROIC 11.13%
Asset turnover 0.57x
ROE 21.87%
Debt
75 /100
Low
Debt/Equity 0.77x
Net debt/EBITDA 0.51x
Current ratio 0.84x
Stability
64 /100
Moderate
Beta 0.11x
Profitable years 6
Rev. volatility 3.41%

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about THLEF
Online

About the company

Thales S.A. is a French multinational technology company founded in 2000, specializing in defense, security, aerospace, and transportation sectors. The company develops and delivers innovative systems and services in electronics, information technology, and communications, which are used in both civil and military applications. Thales focuses on advanced technologies such as cybersecurity, radar systems, and intelligent transportation. The company has a global reach, operating in many countries and providing key solutions for both public and private sectors.

Sector

Industrials

Industry

Aerospace & Defense

CEO

Patrice Caine

Employees

84,958

Headquarters

Meudon

Upcoming events

09 MAR

Earnings

Upcoming earnings report

170d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.